UnitedHealth Group Inc (UNH) Position Boosted by Dorsey Wright & Associates

Dorsey Wright & Associates boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 23.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 14,355 shares of the healthcare conglomerate’s stock after purchasing an additional 2,742 shares during the period. Dorsey Wright & Associates’ holdings in UnitedHealth Group were worth $2,811,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Blue Chip Partners Inc. acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $110,000. Bruderman Asset Management LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the last quarter. BDO Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 2nd quarter worth about $121,000. Finally, Acrospire Investment Management LLC raised its holdings in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the last quarter. Hedge funds and other institutional investors own 86.01% of the company’s stock.

In other news, Director Kenneth Irwin Shine sold 457 shares of the stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total transaction of $96,440.71. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock valued at $7,669,416 over the last ninety days. 0.89% of the stock is currently owned by insiders.

A number of equities research analysts recently weighed in on UNH shares. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a report on Thursday, September 21st. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein restated an “outperform” rating and issued a $210.00 target price on shares of UnitedHealth Group in a report on Tuesday, October 10th. Jefferies Group upped their target price on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock a “buy” rating in a report on Friday, October 13th. Finally, BMO Capital Markets started coverage on shares of UnitedHealth Group in a report on Monday, October 16th. They issued an “outperform” rating and a $250.00 target price on the stock. Three research analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $226.74.

Shares of UnitedHealth Group Inc (UNH) opened at $225.39 on Friday. UnitedHealth Group Inc has a 52-week low of $156.09 and a 52-week high of $231.77. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. The stock has a market cap of $217,920.00, a PE ratio of 25.61, a price-to-earnings-growth ratio of 1.57 and a beta of 0.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same period in the prior year, the firm posted $2.17 EPS. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. equities analysts predict that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “UnitedHealth Group Inc (UNH) Position Boosted by Dorsey Wright & Associates” was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.com-unik.info/2018/01/12/unitedhealth-group-inc-unh-position-boosted-by-dorsey-wright-associates.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit